Meige's syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
(correction)
Line 24: Line 24:
The disease appears between the age of 30-70 years, with a mean onset age of 55.7 years<ref name="pmid30020730">{{cite journal| author=| title=StatPearls | journal= | year= 2024 | volume=  | issue=  | pages=  | pmid=30020730 | doi= | pmc= | url= }} </ref>. It is prevalent in older females than males, with a ratio of 2:1. This may be due to certain estrogen receptors that affect involuntary motor function and make women more vulnerable to experiencing involuntary muscle spasms. The disease is observed in approximately 100 cases per 100,000 people<ref name="pmid28017205">{{cite journal| author=Pandey S, Sharma S| title=Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment. | journal=J Neurol Sci | year= 2017 | volume= 372 | issue=  | pages= 162-170 | pmid=28017205 | doi=10.1016/j.jns.2016.11.053 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28017205  }} </ref>.
The disease appears between the age of 30-70 years, with a mean onset age of 55.7 years<ref name="pmid30020730">{{cite journal| author=| title=StatPearls | journal= | year= 2024 | volume=  | issue=  | pages=  | pmid=30020730 | doi= | pmc= | url= }} </ref>. It is prevalent in older females than males, with a ratio of 2:1. This may be due to certain estrogen receptors that affect involuntary motor function and make women more vulnerable to experiencing involuntary muscle spasms. The disease is observed in approximately 100 cases per 100,000 people<ref name="pmid28017205">{{cite journal| author=Pandey S, Sharma S| title=Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment. | journal=J Neurol Sci | year= 2017 | volume= 372 | issue=  | pages= 162-170 | pmid=28017205 | doi=10.1016/j.jns.2016.11.053 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28017205  }} </ref>.


== '''Etiology'''<ref name="pmid37482394">{{cite journal| author=Steel D, Reid KM, Pisani A, Hess EJ, Fox S, Kurian MA| title=Advances in targeting neurotransmitter systems in dystonia. | journal=Int Rev Neurobiol | year= 2023 | volume= 169 | issue=  | pages= 217-258 | pmid=37482394 | doi=10.1016/bs.irn.2023.06.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=37482394  }} </ref>,<ref name="pmid35044558">{{cite journal| author=Teng X, Qu Q, Shu Y, Gong J, Xu B, Qu J| title=Genetic screening in patients of Meige syndrome and blepharospasm. | journal=Neurol Sci | year= 2022 | volume= 43 | issue= 6 | pages= 3683-3694 | pmid=35044558 | doi=10.1007/s10072-022-05900-8 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35044558  }} </ref>
== '''Etiology'''<ref name="pmid37482394">{{cite journal| author=Steel D, Reid KM, Pisani A, Hess EJ, Fox S, Kurian MA| title=Advances in targeting neurotransmitter systems in dystonia. | journal=Int Rev Neurobiol | year= 2023 | volume= 169 | issue=  | pages= 217-258 | pmid=37482394 | doi=10.1016/bs.irn.2023.06.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=37482394  }} </ref>,<ref name="pmid35044558">{{cite journal| author=Teng X, Qu Q, Shu Y, Gong J, Xu B, Qu J| title=Genetic screening in patients of Meige syndrome and blepharospasm. | journal=Neurol Sci | year= 2022 | volume= 43 | issue= 6 | pages= 3683-3694 | pmid=35044558 | doi=10.1007/s10072-022-05900-8 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35044558  }} </ref> ==


=== '''Genetic dystonia''': ===
=== '''Genetic dystonia''': ===

Revision as of 09:54, 14 June 2024

Meige's syndrome
ICD-10 G24.4
ICD-9 333.82
DiseasesDB 31428
MeSH D008538

WikiDoc Resources for Meige's syndrome

Articles

Most recent articles on Meige's syndrome

Most cited articles on Meige's syndrome

Review articles on Meige's syndrome

Articles on Meige's syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Meige's syndrome

Images of Meige's syndrome

Photos of Meige's syndrome

Podcasts & MP3s on Meige's syndrome

Videos on Meige's syndrome

Evidence Based Medicine

Cochrane Collaboration on Meige's syndrome

Bandolier on Meige's syndrome

TRIP on Meige's syndrome

Clinical Trials

Ongoing Trials on Meige's syndrome at Clinical Trials.gov

Trial results on Meige's syndrome

Clinical Trials on Meige's syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Meige's syndrome

NICE Guidance on Meige's syndrome

NHS PRODIGY Guidance

FDA on Meige's syndrome

CDC on Meige's syndrome

Books

Books on Meige's syndrome

News

Meige's syndrome in the news

Be alerted to news on Meige's syndrome

News trends on Meige's syndrome

Commentary

Blogs on Meige's syndrome

Definitions

Definitions of Meige's syndrome

Patient Resources / Community

Patient resources on Meige's syndrome

Discussion groups on Meige's syndrome

Patient Handouts on Meige's syndrome

Directions to Hospitals Treating Meige's syndrome

Risk calculators and risk factors for Meige's syndrome

Healthcare Provider Resources

Symptoms of Meige's syndrome

Causes & Risk Factors for Meige's syndrome

Diagnostic studies for Meige's syndrome

Treatment of Meige's syndrome

Continuing Medical Education (CME)

CME Programs on Meige's syndrome

International

Meige's syndrome en Espanol

Meige's syndrome en Francais

Business

Meige's syndrome in the Marketplace

Patents on Meige's syndrome

Experimental / Informatics

List of terms related to Meige's syndrome


Not to be confused with Meigs syndrome

Dystonia is a neurological disorder that causes involuntary movements of muscles due to a disturbance in the brain's neural network. Meige's syndrome is a type of facial distonia. It is also known as Brueghel Syndrome; however this term is more often used for the condition of oromandibular distonia only in the absence of blepharospasm. Meige's syndrome affects the muscles in the tongue, eyes, jaw, pharynx, and neck. It is also referred to as blepharospasm, oromandibular, platysma, and cervical dystonia, respectively[1]. These are different but closely related moment disorder[2],[3].The disorder was first identified by French neurologist Henry Meige in the 20th century, who referred to it as “spasm facial median”. Later, in 1972, Dr. George Paulson introduced the term Magee's syndrome and defined it as the involuntary movements of the oromandibular and blepharospasm [4],[5].


Epidemiology

The disease appears between the age of 30-70 years, with a mean onset age of 55.7 years[6]. It is prevalent in older females than males, with a ratio of 2:1. This may be due to certain estrogen receptors that affect involuntary motor function and make women more vulnerable to experiencing involuntary muscle spasms. The disease is observed in approximately 100 cases per 100,000 people[1].

Etiology[7],[8]

Genetic dystonia:

It is caused by gene variants including TOR1A, TOR2A, GNAL, OR1A, REEP4, and THAP1, respectively. TOR1A and THAP1 play a significant role in the pathophysiology of the disease.

Acquired dystonia:

It is caused by environmental factors such as medical conditions including (trauma, cerebral palsay, stroke, encephalopathy, etc), medications, and poisons including (heavy metal toxicity, antipsychotic medication, and others).

Presentations [9],[10],[11]

Blepharospasm affects the eyelid and increases blinking along with ocular pain but due to the disease progressing to oromandibular dystonia patient experiences involuntary tongue movements and has difficulty with eating, swallowing, laughing, speaking, and yawning. These symptoms persist until the patients consciously relax. Emotional stress can worsen diseases in around 33% of patients this can be shown by symptoms such as sleeplessness, sadness, and increased muscular tension.

Blepharospasm related symptoms  

  •     Eyelid fluttering
  •     Exaggerated blinking
  •     Apraxia  of eyelid opening
  •      Involuntary closing of the eye
  •      Discomfort in opening eye
  •      Blindness
  •      Photophobia
  •      Dry eyes

Oromandibular dystonia related symptoms:

  • Unilateral retraction of the lip cheek, and jaw
  •     Jaw pain
  •     Difficulty in opening and closing mouth
  •     Trismus,
  •      Bruxism
  • Stuck teeth

Diagnosis

Meige's syndrome is a rare disease normally diagnosed using a patient's medical history, external observations, and neurological examination. There is no particular test to identify Meige's syndrome, several procedures are conducted to rule out other probable causes. These might include genetic screening, face electromyography, VBM-MRI, CT, serum testing for SSA/SSB levels, serum copper and ceruloplasmin levels, Beck's depression inventory, and serum drug screening [12].

Treatment

There is currently no known cure for MS, however medical therapy can help decrease discomfort and improve a patient's quality of life. The sort of treatment is administered based on the patient's medical condition and history. Treatment options include surgery(e.g partial resection of the periorbital muscle, which surrounds the eye) medication (given orally) are anticholinergics (trihexyphenidyl and benztropine), benzodiazepines (clonazepam, diazepam, and lorazepam), GABA receptor agonist (baclofen), dopamine precursor(bromocriptine, and tiapride), vesicular monoamine transporter 2 inhibitor (tetrabenazine), anticonvulsant such as levetiracetam[13]. and rehabilitative treatment (include physiotherapy, occupational therapy) and BoNT injection it is used as a primary treatment option for MS it help to reduced muscle spasm[10]. When other treatments are failed to control the disease then Deep brain stimulation of the globus pallidus interna (GPi) is a therapeutic approach[14].

See also

Reference

  1. 1.0 1.1 Pandey S, Sharma S (2017). "Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment". J Neurol Sci. 372: 162–170. doi:10.1016/j.jns.2016.11.053. PMID 28017205.
  2. Ma H, Qu J, Ye L, Shu Y, Qu Q (2021). "Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update". Front Neurol. 12: 630221. doi:10.3389/fneur.2021.630221. PMC 8039296 Check |pmc= value (help). PMID 33854473 Check |pmid= value (help).
  3. Zhu L, Meng H, Zhang W, Xie W, Sun H, Hou S (2023). "The pathogenesis of blepharospasm". Front Neurol. 14: 1336348. doi:10.3389/fneur.2023.1336348. PMC 10808626 Check |pmc= value (help). PMID 38274886 Check |pmid= value (help).
  4. Aires A, Gomes T, Linhares P, Cunha F, Rosas MJ, Vaz R (2018). "The impact of deep brain stimulation on health related quality of life and disease-specific disability in Meige Syndrome (MS)". Clin Neurol Neurosurg. 171: 53–57. doi:10.1016/j.clineuro.2018.05.012. PMID 29807200.
  5. Sellal F, Frismand S (2019). "Cervico-facial dystonia as depicted in sculpture before its scientific description". Rev Neurol (Paris). 175 (3): 198–200. doi:10.1016/j.neurol.2018.05.006. PMID 30658849.
  6. "StatPearls". 2024. PMID 30020730.
  7. Steel D, Reid KM, Pisani A, Hess EJ, Fox S, Kurian MA (2023). "Advances in targeting neurotransmitter systems in dystonia". Int Rev Neurobiol. 169: 217–258. doi:10.1016/bs.irn.2023.06.002. PMID 37482394 Check |pmid= value (help).
  8. Teng X, Qu Q, Shu Y, Gong J, Xu B, Qu J (2022). "Genetic screening in patients of Meige syndrome and blepharospasm". Neurol Sci. 43 (6): 3683–3694. doi:10.1007/s10072-022-05900-8. PMID 35044558 Check |pmid= value (help).
  9. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1136/jnnp-2019-321794 DOI: 10.1136/jnnp-2019-321794 Check |pmid= value (help).
  10. 10.0 10.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID DOI:10.20961/magnaneurologica.v1i2.700 Check |pmid= value (help).
  11. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.4103/NJM.NJM_84_23 DOI: 10.4103/NJM.NJM_84_23 Check |pmid= value (help).
  12. "StatPearls". 2024. PMID 30020730 PMID: 30020730 Check |pmid= value (help).
  13. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID doi.org/10.3389/fneur.2021.630221 Check |pmid= value (help).
  14. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.3171/2023.11.JNS232075 DOI: 10.3171/2023.11.JNS232075 Check |pmid= value (help).